07/17/2025
7:12 PM | BlackRock, Inc. (Filed by)
LIFECORE BIOMEDICAL, INC. \DE\ (Subject)
Lifecore Biomedical (Subject)
| Form SCHEDULE 13G | |
07/17/2025
5:36 PM | Kiper Christopher S (Reporting)
Legion Partners Asset Management, LLC (Reporting)
Legion Partners Holdings, LLC (Reporting)
Legion Partners, L.P. I (Reporting)
Legion Partners, L.P. II (Reporting)
Legion Partners, LLC (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
White Raymond T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
5:48 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
OBUS NELSON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
3:36 PM | HOUDE LOVAS KATRINA (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
8:56 PM | 22NW Fund, LP (Filed by)
LIFECORE BIOMEDICAL, INC. \DE\ (Subject)
Lifecore Biomedical (Subject)
| Form SCHEDULE 13D/A | |
05/28/2025
7:06 PM | 22NW Fund GP, LLC (Reporting)
22NW Fund, LP (Reporting)
22NW GP, Inc. (Reporting)
22NW, LP (Reporting)
English Aron R. (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
12:43 PM | Josephs Paul (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
10:28 AM | 22NW Fund GP, LLC (Reporting)
22NW Fund, LP (Reporting)
22NW GP, Inc. (Reporting)
22NW, LP (Reporting)
English Aron R. (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
5:58 PM | 22NW Fund GP, LLC (Reporting)
22NW Fund, LP (Reporting)
22NW GP, Inc. (Reporting)
22NW, LP (Reporting)
English Aron R. (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
8:09 PM | 22NW Fund GP, LLC (Reporting)
22NW Fund, LP (Reporting)
22NW GP, Inc. (Reporting)
22NW, LP (Reporting)
English Aron R. (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
3:37 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
Salus Thomas D. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for LFCR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter. |
04/16/2025
3:38 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
Salus Thomas D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
3:46 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2025
3:23 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/14/2025
3:44 PM | Greenhaven Road Investment Management, L.P. (Filed by)
LIFECORE BIOMEDICAL, INC. \DE\ (Subject)
Lifecore Biomedical (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
3:44 PM | Greenhaven Road Investment Management, L.P. (Filed by)
LIFECORE BIOMEDICAL, INC. \DE\ (Subject)
Lifecore Biomedical (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
2:24 PM | David Capital Partners, LLC (Filed by)
LIFECORE BIOMEDICAL, INC. \DE\ (Subject)
Lifecore Biomedical (Subject)
| Form SCHEDULE 13G/A | |
01/21/2025
4:16 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form PRE 14A | |
01/17/2025
4:27 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
4:27 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form DEFA14A | |
01/08/2025
3:10 PM | Josephs Paul (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
8:07 AM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
4:15 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/02/2025
3:15 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
12:20 PM | 22NW Fund, LP (Filed by)
LIFECORE BIOMEDICAL, INC. \DE\ (Subject)
Lifecore Biomedical (Subject)
| Form SCHEDULE 13D/A | |
12/10/2024
3:26 PM | Lake Ryan David (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
4:29 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
6:55 AM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
9:14 AM | LIFECORE BIOMEDICAL, INC. \DE\ (Subject)
Lifecore Biomedical (Subject)
Morberg John D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
1:43 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Subject)
Lifecore Biomedical (Subject)
Morberg John D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:18 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Subject)
Lifecore Biomedical (Subject)
Morberg John D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
3:46 PM | Lake Ryan David (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
3:04 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 424B3 | |
10/22/2024
11:15 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form EFFECT | |
10/15/2024
11:15 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form EFFECT | |
10/10/2024
3:37 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/10/2024
3:38 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/10/2024
3:40 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/10/2024
3:36 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form POS AM | |
10/07/2024
7:45 PM | LANDES JOSHUA (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
OBUS NELSON (Reporting)
WYNNEFIELD CAPITAL INC (Reporting)
WYNNEFIELD CAPITAL MANAGEMENT LLC (Reporting)
Wynnefield Capital, Inc. Profit Sharing Plan (Reporting)
WYNNEFIELD PARTNERS SMALL CAP VALUE LP (Reporting)
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I (Reporting)
WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
12:03 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Subject)
Lifecore Biomedical (Subject)
Morberg John D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Missed the Run So Far? This Is Your Second Chance (Ad) According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made.
Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up. Join The Crypto Code Workshop + get $10 in Bitcoin for attending |
10/04/2024
6:41 AM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/04/2024
6:36 AM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:14 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:21 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form DEF 14A | |
09/16/2024
2:24 PM | Antunes Humberto Calheiros (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4/A | |
09/12/2024
6:09 AM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:18 PM | Lake Ryan David (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:20 AM | Lake Ryan David (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/26/2024
4:26 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
3:21 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
08/22/2024
2:00 PM | Johnson Paul Harold (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
1:45 PM | Johnson Paul Harold (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2024
6:51 PM | Antunes Humberto Calheiros (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2024
6:52 PM | Korenberg Matthew E (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
6:54 PM | Aryeh Jason (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
6:55 PM | Antunes Humberto Calheiros (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
5:25 PM | Aryeh Jason (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2024
5:27 PM | Korenberg Matthew E (Reporting)
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer)
Lifecore Biomedical (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
7:01 AM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form NT 10-K | |
08/09/2024
4:13 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
4:14 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
4:15 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024
3:20 PM | LIFECORE BIOMEDICAL, INC. \DE\ (Filer)
Lifecore Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
